Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Ronald D. Alvarez, MD, MBA, Chair

Vanderbilt University Medical Center

Deborah K. Armstrong, MD

Johns Hopkins School of Medicine

Robert C. Bast Jr., MD

MD Anderson Cancer Center

Andrew Berchuck, MD

Duke Comprehensive Cancer Center

Jonathan S. Berek, MD, MMS

Stanford University School of Medicine

Benjamin Bitler, PhD

University of Colorado

Molly Brewer, DVM, MD, MS

University of Connecticut Health Center

Ronald Buckanovich, MD, PhD

Magee-Womens Research Institute

Jeremy Chien, PhD

California Davis School of Medicine

Kathleen Cho, MD

University of Michigan Medical School

Robert L. Coleman, MD

Vaniam Group

Jose Conejo-Garcia, MD, PhD

Duke University

Oliver Dorigo, MD, PhD

Stanford University

Katherine Fuh, MD, PhD

University of California, San Francisco

Gillian Hanley, PhD

University of British Columbia

Gwen Harding-Peets, PhD

Patient Advocate

David Huntsman, MD, FRCPC, FCCMG

University of British Columbia

Beth Y. Karlan, MD

UCLA Medical Center

Dineo Khabele, MD

Washington University School of Medicine in St. Louis

Daniela Matei, MD

Northwestern University Feinberg School of Medicine

Ursula Matulonis, MD, Grants Oversight Chair

Dana-Farber Cancer Institute

Kathleen Moore, MD, MS

University of Oklahoma Health Sciences Center

Kenneth Nephew, PhD

University of Indiana

Sandra Orsulic, PhD

David Geffen School of Medicine at the University of California, Los Angeles (UCLA)

Leigh Pearce, PhD, MPH

University of Michigan

Carolyn D. Runowicz, MD

Florida International University

Sohrab Shah, PhD

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College

Ie-Ming Shih, MD, PhD

Johns Hopkins University School of Medicine

Anil K. Sood, MD

MD Anderson Cancer Center

Kathryn Terry, ScD

Harvard T.H. Chan School of Public Health

Shelley Tworoger, PhD

Oregon Health and Science Center

Jason D. Wright, MD

Columbia University Medical Center

Former Members

Jeff Boyd, PhD
Carmel J. Cohen, MD
Alan D. D’Andrea, MD
Ronny I. Drapkin, MD, PhD
Annie Ellis
Ellen L. Goode, PhD
Susan Leighton
Ernst Lengyel, MD, PhD
Douglas A. Levine, MD
Joyce Liu, MD
Carolyn Muller, MD, FACOG
Kunle Odunsi, MD, PhD
Bob Ozols, MD, PhD
Daniel J. Powell Jr., PhD
Stephen C. Rubin, MD
Michael Seiden, MD, PhD
Elizabeth Swisher, MD

Related Topics

The Overview: May 2026

When Ovarian Cancer Research Alliance (OCRA) announced the launch of the Community Accelerated Research Exchange on World Ovarian Cancer Day, the response was immediate. More than 280 media mentions. Over 171 million people reached. Television and radio coverage in English and Spanish, in markets from San Francisco to Albany. The excitement is building—and it’s just … Continued

OCRA’s Research Exchange Announcement Reaches Over 171 Million

AI-Powered Platform Launch Sparks Nationwide Conversation The response to OCRA’s launch of the Community Accelerated Research Exchange was immediate and far-reaching. News outlets across the country picked up the story, generating more than 280 media mentions and reaching over 171 million people—a sign of just how much this groundbreaking platform, designed to connect patients, researchers, … Continued

OCRA-Funded ROCCA Platform Launches to Accelerate Rare Ovarian Cancer Research

OCRA is proud to announce the launch of the Rare Ovarian Cancer Collaborative Analytics (ROCCA) Platform, an international federated data network funded by OCRA to connect researchers globally and accelerate breakthroughs in rare ovarian cancer research. A collaborative approach to research for rare ovarian cancer ROCCA is launching with two foundational projects: one in mucinous … Continued

Scientific Advisory Committee